CAMBRIDGE, Mass.--(BUSINESS WIRE)--Visterra, Inc., a clinical-stage biotechnology company that uses its proprietary technology platform to identify unique disease targets and design novel therapeutics for infectious diseases, today announced that it has appointed John Weidenbruch as General Counsel and Secretary of the Board of Directors.
Help employers find you! Check out all the jobs and post your resume.